Real world study comparing effect of Cangrelor versus Glycoprotein IIb/IIIa Inhibitors in patients undergoing percutaneous coronary intervention (PCI)
Latest Information Update: 18 May 2021
At a glance
- Drugs Cangrelor (Primary) ; Glycoprotein inhibitors
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 18 May 2021 New trial record
- 04 May 2021 Results published in the American Heart Journal